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The generation of induced pluripotent stem cells (iPSCs) from differentiated mature cells is 
one of the most promising technologies in the field of regenerative medicine. The ability to 
generate patient-specific iPSCs offers an invaluable reservoir of pluripotent cells, which could 
be genetically engineered and differentiated into target cells to treat various genetic and 
degenerative diseases once transplanted, hence counteracting the risk of graft versus host 
disease. In this context, we review the scientific research streams that lead to the emergence of 
iPSCs, the roles of reprogramming factors in reprogramming to pluripotency, and the 
reprogramming strategies. As iPSCs serve tremendous correction potentials for various 
diseases, we highlight the successes and challenges of iPSCs in cell replacement therapy and 
the synergy of iPSCs and clustered regularly interspaced short palindromic repeats 
(CRISPR)/Cas9 gene editing tools in therapeutics research. 
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